Last reviewed: May 29, 2026

Last updated: May 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

NAD+ (nicotinamide adenine dinucleotide) injections are designed to boost cellular NAD+ levels, which decline with age and may affect mitochondrial function and energy metabolism. Research suggests NAD+ precursors can increase circulating NAD+ levels, though individual response varies significantly based on baseline metabolic status and genetic factors.

Before starting NAD+ therapy, understanding your metabolic baseline and genetic predispositions can help set realistic expectations and support a more informed conversation with your healthcare provider about whether this treatment aligns with your health goals and current biomarker profile.

How NAD+ Injections Work at the Cellular Level

NAD+ functions as a critical coenzyme in energy metabolism, DNA repair, and cellular signaling pathways. As NAD+ levels decline with age, mitochondrial function and sirtuin activation may be compromised, potentially affecting energy production and metabolic health. Injectable NAD+ precursors aim to replenish these levels.

The mechanism relies on systemic absorption and cellular uptake. Once NAD+ or its precursors enter circulation, cells can convert them into usable NAD+. However, absorption efficiency, liver metabolism, and individual enzyme activity significantly influence how much reaches target tissues.

NAD+ Dosing Protocols and Treatment Timelines

Standard NAD+ injection protocols typically range from 250 mg to 1000 mg per injection, administered intravenously or intramuscularly. Loading phases often involve twice-weekly injections for 4 to 8 weeks, followed by maintenance dosing at weekly or bi-weekly intervals. Dosing depends on age, weight, baseline NAD+ status, and treatment goals.

Protocol Phase Typical Dosing Frequency Expected Duration
Loading Phase 500–1000 mg per injection 2× weekly 4–8 weeks
Early Maintenance 500 mg per injection Weekly 8–12 weeks
Long-term Maintenance 250–500 mg per injection Bi-weekly to monthly Ongoing
Individual Adjustment Dose reduced or increased based on response Provider-determined Flexible

Biomarker Assessment Before NAD+ Therapy Begins

Baseline biomarkers provide clinical context for NAD+ candidacy and help predict how your body may respond. Key markers include mitochondrial function indicators (lactate, pyruvate ratios), oxidative stress markers (8-OHdG, malondialdehyde), and metabolic markers (fasting glucose, lipid profile, insulin sensitivity). These should be assessed before starting treatment.

Low baseline NAD+ levels, elevated oxidative stress, or markers of mitochondrial dysfunction may indicate stronger candidates for NAD+ therapy. Conversely, normal metabolic markers and high energy levels may suggest limited benefit. Your provider should evaluate these results alongside symptoms and health objectives to determine if NAD+ injections are appropriate.

Safety Considerations, Side Effects, and Who Should Avoid NAD+ Therapy

NAD+ injections are generally well tolerated, but common side effects include flushing, headache, nausea, and mild injection-site reactions. These often diminish with continued use. More serious adverse events are rare but can include histamine release reactions, particularly at higher doses. Medical supervision is essential during loading phases.

NAD+ therapy may not be appropriate for individuals with active cancer, uncontrolled infections, severe liver or kidney disease, or history of severe allergic reactions. Pregnant and breastfeeding individuals should avoid NAD+ injections. A qualified healthcare provider must evaluate contraindications and review all medications before initiating treatment.

How PlexusDx Supports a More Personalized Approach

While PlexusDx specializes in compounded peptide therapies (semaglutide, tirzepatide, and GLP-1 compounds), we recognize that metabolic wellness involves multiple pathways. Understanding baseline mitochondrial function and metabolic biomarkers can provide important context for any cellular energy or longevity protocol—including NAD+ therapy. These insights may help support a more holistic conversation with your provider.

PlexusDx's Precision Peptide Genetic Test reveals predispositions in key metabolic pathways (FTO rs9939609, MC4R rs17782313, and others) that influence energy expenditure, metabolic flexibility, and insulin sensitivity. While this test doesn't directly predict NAD+ response, these genetic insights can help contextualize your metabolic baseline and inform discussions about which wellness interventions may align with your genetic predispositions.

If you're considering NAD+ injections alongside other metabolic therapies, consulting with a provider who understands both your genetic predispositions and biomarker profile can help coordinate your entire wellness strategy. PlexusDx can support this conversation by providing genetic context; a qualified clinician should oversee all treatment decisions.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $179-$229/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How long does it take to see results from NAD+ injections?

Many people report improved energy, focus, or sleep within 2 to 4 weeks of starting NAD+ therapy. However, optimal cellular effects may take 8 to 12 weeks. Results vary widely based on baseline NAD+ levels, age, metabolic health, and adherence to the treatment protocol.

What does research say about NAD+ and aging?

Studies show NAD+ declines approximately 50% between ages 20 and 60, correlating with mitochondrial dysfunction and reduced sirtuin activity. Animal and preliminary human research suggest NAD+ restoration may improve energy metabolism and cellular repair, though long-term human outcome data remains limited.

Can I combine NAD+ injections with other wellness treatments?

NAD+ injections can often be combined with other therapies, but interactions and synergistic effects depend on the specific compounds. Your healthcare provider must review all medications and treatments to ensure safety and efficacy. Combining approaches should always be coordinated with medical supervision.

What are the most common side effects of NAD+ injections?

Flushing, headache, nausea, and mild injection-site discomfort are the most frequently reported side effects. These typically diminish after the first few injections. Severe allergic reactions are rare but possible; inform your provider immediately if you experience breathing difficulty or severe itching.

Does PlexusDx offer NAD+ injections?

PlexusDx specializes in compounded peptide therapies (semaglutide, tirzepatide, and GLP-1 protocols) sourced from licensed 503A compounding pharmacies. For NAD+ therapy, consult a qualified healthcare provider. PlexusDx's Precision Peptide Genetic Test can help contextualize your metabolic pathways for broader wellness planning.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves